Aeglea BioTherapeutics Inc Stock Price (AGLE)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Invesco DWA Healthcare Momentum ETF (NYSEARCA:PTH) Shares Down 0.6%Fri, 1 Jul 2022 02:00:52 UTC via ETF Daily News
Bellevue Healthcare Trust plc (LON:BBH) Insider Randeep Singh Grewal Acquires 7,075 Shares of StockFri, 1 Jul 2022 01:22:48 UTC via ETF Daily News
Hedge Forecast Price Ranges For CURE, Healthcare ETFs And StocksThu, 30 Jun 2022 13:22:07 UTC via Seeking Alpha
Is Clover Health A Good Healthcare Sector Stock Pick?Thu, 30 Jun 2022 09:00:00 UTC via Seeking Alpha
Spire Wealth Management Has $1.24 Million Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)Thu, 30 Jun 2022 05:32:51 UTC via ETF Daily News
Principal Healthcare Innovators ETF (NASDAQ:BTEC) Shares Sold by Creative Financial Designs Inc. ADVThu, 30 Jun 2022 04:44:40 UTC via ETF Daily News
Short Interest in Isleworth Healthcare Acquisition Corp. (NASDAQ:ISLE) Grows By 148.6%Thu, 30 Jun 2022 03:08:41 UTC via ETF Daily News
iShares Global Healthcare ETF (NYSEARCA:IXJ) Sees Unusually-High Trading VolumeWed, 29 Jun 2022 05:12:50 UTC via ETF Daily News
Ritholtz Wealth Management Sells 1,230 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)Wed, 29 Jun 2022 04:38:47 UTC via ETF Daily News
Comparing EVI Industries (NYSE:EVI) & MEDIROM Healthcare Technologies (NYSE:MRM)Wed, 29 Jun 2022 04:24:42 UTC via ETF Daily News

Aeglea BioTherapeutics Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:AGLE

You don't have any alerts set for IEX:AGLE.

About Aeglea BioTherapeutics Inc

Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.

CEOAnthony G. Quinn IndustryBiotechnology SectorHealthcare Websitehttps://www.aegleabio.com Issue ExchangeNASDAQ Global Market Issue TypeUnknown

Real-time AGLE to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.